AI-designed molecular switch uses caffeine to control engineered cells
For many of us, a warm cup of coffee is how we start our day. For Texas A&M…
Improved non-invasive brain stimulation targets deep-seated neurological disorders
Brain stimulation techniques can correct abnormal activity in the neural circuits involved in conditions such as Parkinson’s disease…
Researchers develop compound 10 to slow Alzheimer’s disease progression
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms…
Study reveals how germinal centers consistently produce antibodies
A new study tracking thousands of B cells across more than 100 germinal centers in mice reveals how…
Popular supplement creatine supercharges critical immune cells fighting cancer
Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical…
Three decades of progress since the discovery of senescence-associated beta-galactosidase
A new review was published in Volume 18 of Aging on May 15, 2026, titled “Blue period – features of…
Study validates research models for tracking circular extra-chromosomal DNA
Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs…
Flu drugs may reduce cognitive decline in people with HIV
A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral…
Novel technology maps single-cell DNA-protein interactions
A new technology allows scientists to map, in single cells, the DNA binding sites of transcription factors and…
Early glucocorticoid tapering reduces damage in vasculitis maintenance therapy
Glucocorticoids are the cornerstone of initial vasculitis treatment, used to rapidly control inflammation and protect vital organs. EULAR –…
Blood protein signature can predict lung cancer risk before diagnosis
Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the…
Study potentially opens a new route to more selective cancer drug design
Researchers at the Icahn School of Medicine at Mount Sinai have identified a previously hidden druggable site in…